Braveheart announces that on 6 November 2020 it exercised a total of 10 million options over ordinary shares in Remote Monitored Systems plc (“RMS”) at an exercise price of 0.5p
Novacyt S.A. (NCYT.L) Launch of COVID-19 antibody test
Paris, France and Camberley, UK – 29 September 2020 – Novacyt, an international specialist in clinical diagnostics, announces that, further to the announcement on 27 July 2020, the Company has
Symphony Environment (SYM.L) Positive Coronavirus test results
Positive Coronavirus test results in shorter timescales
Braveheart Inv Group (BRH.L) Conditional Sale of Pharm 2 Farm Limited holding
Conditional Sale of Pharm 2 Farm Limited holding to Remote Monitored Systems plc
Braveheart Inv Group (BRH.L) Further re Paraytec Limited
Further to the announcement made on 7 July 2020, Braveheart is pleased to provide an update concerning the development of a COVID-19 test that Paraytec Limited is conducting with the
Novacyt S.A. (NCYT.L) Significant new opportunities for growth
Paris, France and Camberley, UK – 27 July 2020 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces an R&D update.
Novacyt S.A. (NCYT.L) Sales and regulatory update
Paris, France and Camberley, UK – 2 June 2020 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, provides an update on its polymerase